Links to other sites are provided as a convenience to the viewer.
Pfizer accepts no responsibility for the content of linked sites.
DuoDote, a combination of atropine, a cholinergic muscarinic antagonist, and pralidoxime chloride, a cholinesterase reactivator, is indicated for the treatment of poisoning by organophosphorus nerve agents as well as organophosphorus insecticides in adults and pediatric patients weighing more than 41 kg (90 pounds).
|Key Product Specifications6:|
|Delivers||2.1 mg atropine in 0.7 mL and 600 mg pralidoxime chloride in 2 mL sequentially through a single needle using the two-chambered BinaJect® drug delivery system.|
|Length of Unit||145 mm|
|Diameter of Unit||19 mm|
|Needle Length||21 mm|
|Administration Type||Intramuscular injection|
|Packaged||1 auto-injector per box with instructions; package insert|
|Packaging for Shipping||30 units per shipper box (286 mm x 213 mm x 210 mm), weighing 2.3 kg|
|Storage||Store at 25°C (77°F); excursions permitted to 15°C-30°C (59°F-86°F) [See USP Controlled Room Temperature]. Keep from freezing. Protect from light.|
DuoDote Mechanism of Action
How to Administer DuoDote
Adverse Event or Product Quality Complaints
If you wish to report an adverse event or product quality complaint, please call 1-800-438-1985.
For medical questions concerning Meridian products, to report an adverse event, or to speak to a member of Pfizer US Medical Information, please call 1-800-438-1985.